Director, HEOR Strategy - Oncology

Benefits

Parental leave

12 weeks From the posting source

Non-birth-parent leave

12 weeks From the posting source

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Source-linked checked May 7, 2026

Salary

Not verified

401(k) match

Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$102,662 U.S. median for this role

Projected growth (BLS Employment Projections)

+5.4% - Faster than average

Matched to SOC 11-1021 - Product Management aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function

Product From the posting source

Seniority

Staff Plus From the posting source

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Equity

Offered Verified - SEC 10-K source

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Director, HEOR Strategy - Oncology Mettawa, IL, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: The Oncology HEOR Strategy team, within the MHI Value & Evidence function, leads the creation and communication of transformative evidence to shape healthcare decision-making and make a remarkable impact for patients. Director, HEOR Strategy, CLL & Heme-Oncology (HEOR-S) - directs, develops, organizes, and implements the V&E strategy for Chronic Lymphocytic Leukemia (CLL) and disease adjacencies with concurrence of functional management to allow the development of each asset to proceed expeditiously and smoothly toward registration, PR&A and market launch in compliance with national and international governmental regulations for various asset programs, including CLL adjacencies. HSL reports to Senior Director, Heme-Oncology HEOR Strategy Team Lead and may have direct reports. Responsibilities Accountable for engagement and co-creation of holistic value evidence strategy with V&E pillars and cross-functional partners for Oncology disease areas/assets/brands, including co-creation of PCM deliverables, MHI Worldwide Scientific Plan, and Value & Evidence Plans (VEP) and ensuring timely relevance to disease area strategy, product development, competitive landscape, and the marketplace.

Read the full description at jobs.smartrecruiters.com. FewerJobs shows a preview and links to the original posting.